Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · MUN · EUR · DE

F6T:MUN is the public listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, Fate Therapeutics is focused on advancing its innovative therapies through extensive research and development in regenerative medicine. The company has a market capitalization of approximately €280.9 million, reflecting its position in the biotech sector. Recent news and filings may provide insights into its ongoing projects and strategic direction.

F6T:MUNEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
F6T:MUN
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
MUN
Currency
EUR

Fate Therapeutics, Inc. F6T:MUN stock context

F6T:MUN is the public listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, Fate Therapeutics is focused on advancing its innovative therapies through extensive research and development in regenerative medicine. The company has a market capitalization of approximately €280.9 million, reflecting its position in the biotech sector. Recent news and filings may provide insights into its ongoing projects and strategic direction.

Research Fate Therapeutics, Inc.

Alternate listings